热门资讯> 正文
BioCryst Pharmaceuticals任命Donald Fong为首席医疗官
2024-09-05 19:17
- BioCryst Pharmaceuticals (NASDAQ:BCRX) said it has appointed Donald Fong as its new chief medical officer, effective immediately.
- Fong had joined the company in April 2024 as vice president of the ophthalmology therapeutic area,
More on BioCryst Pharmaceuticals
- Betting On BioCryst Pharmaceuticals: Orladeyo's Success Fuels Future Prospects
- Piper lists eight defensive biotechs to face market volatility
- BioCryst up 8% after raising 2024 Orladeyo revenue guidance
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。